Description: Activation of TAL1 characterizes up to 60% of cases of human T cell acute lymphoblastic leukemia, making it the most frequent gain-of-function mutation observed in this disorder. TAL1 (also designated SCL) is a serine phosphoprotein and basic helix-loop-helix transcription factor known to regulate embryonic hematopoiesis. This transcription factor binds as a heterodimer with E2A and HEB/HTF4 to a nucleotide sequence motif termed the E-box. In addition, leukemogenesis is accelerated dramatically by transgenic co-expression of TAL1 and the catalytic subunit of casein kinase IIHLH transcription factors. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.
Product Origin: Animal - Mus musculus (mouse), Bos taurus (bovine)
Conjugate: CF740
Concentration: 0.1 mg/mL
Storage buffer: PBS, 0.1% rBSA, 0.05% azide
Clone: BTL73
Immunogen: Recombinant human full-length TAL1 protein
Antibody Reactivity: Tal1
References: Note: References for this clone sold by other suppliers may be listed for expected applications.
- EMBO J (1997) 16:3145-3157. (WB)
- Br J Haematol (1998) 102: 449-457. (Flow; IHC)
- Blood (2002) 100(2): 491-500. (WB; IHC, FFPE; EMSA)
- Oncogene (2011) 30: 1252-1260. (CHiP)
Entrez Gene ID: 6886
Expected AB Applications: IHC (published for clone)/ChiP (published for clone)/EMSA (published for clone)/Flow (intracellular) (published for clone)/IHC (FFPE) (published for clone)
Z-Antibody Applications: CHiP (published)/Flow, intracellular (published)/IHC (published)/IHC, FFPE (published)/EMSA (published)
Antibody Application Notes: ELISA: For coating, order antibody without BSA; Western blot 0.5-1.0 ug/mL; Optimal dilution for a specific application should be determined./Higher concentration may be required for direct detection using primary antibody conjugates than for indirect detection with secondary antibody